ORIC Pharmaceuticals Inc.
10.65
0.74 (7.47%)
At close: Jan 15, 2025, 12:03 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -100.70M -89.12M -78.72M -73.70M -26.88M -21.36M -22.03M
Depreciation & Amortization 1.03M 966.00K 897.00K 970.00K 1.03M 903.00K 900.00K
Stock-Based Compensation 15.23M 14.46M 12.85M 5.28M 1.09M 469.00K 217.00
Other Working Capital 1.62M 1.03M 1.14M -2.26M 234.00K -297.00K 89.00K
Other Non-Cash Items -6.15M -1.00M 1.35M 19.84M 8.00K 15.00K 2.00M
Deferred Income Tax n/a n/a n/a 299.00K n/a n/a n/a
Change in Working Capital 4.90M -445.00K 4.07M 2.04M 1.22M -707.00K 95.00K
Operating Cash Flow -85.69M -75.14M -59.54M -45.27M -23.53M -20.68M -20.83M
Capital Expenditures -849.00K -2.08M -939.00K -667.00K -768.00K -525.00K -486.00K
Acquisitions n/a 2.08M 1.38M n/a n/a n/a n/a
Purchase of Investments -239.24M -238.12M -69.63M -225.49M n/a n/a n/a
Sales Maturities Of Investments 196.69M 130.95M 229.00M 10.00M n/a n/a n/a
Other Investing Acitivies n/a -2.08M -1.38M 193.00K n/a 17.00K 194.00K
Investing Cash Flow -43.40M -109.25M 158.44M -215.96M -768.00K -508.00K -292.00K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 1.54M 225.00K -866.00K -20.79M 70.82M 38.01M n/a
Financial Cash Flow 85.66M 25.62M 49.13M 250.51M 70.82M 38.01M 260.00K
Net Cash Flow -43.43M -159.17M 148.03M -10.71M 46.52M 16.82M -20.86M
Free Cash Flow -86.54M -77.22M -60.48M -45.94M -24.30M -21.21M -21.32M

Create Price Alert on ORIC

Your price alert will notify you when the stock price is above 10.65.

Add to Watchlist